|
Home
|
|
Symptoms
|
|
Live Discussion
|
|
Diagnosis
|
|
Treatment
|
|
World-wide Support Finder
|
|
Library
|
|
Research
|
|
Lymelinks
|
|
Contact
|
|
Pets & Lyme
|
|
DONATIONS
|
|
Drug Info
|
|
Medical Dictionary
|
|
Board of Directors
|
|
|
No Warranties or Representations
The data and information presented in this web site are presented in good faith and believed to be accurate regarding Lyme disease (commonly misspelled lymes disease lyme's disease lime disease limes disease) and other related diseases. Any and all liability for the content or any omissions including any inaccuracies, errors, or misstatements in such data or information is expressly disclaimed. The web site is compiled for the sole purpose of informing community members of resources and information pertaining to Lyme Borreliosis Disease and its coinfections. Lyme disease symptoms may vary from person to person.
The Canadian Lyme Disease Foundation, Directors and members are not liable for any direct or indirect damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action arising out of or in connection with the use or performance of information available from this website.
Consult a qualified Lyme ( Borreliosis ) Disease literate doctor for medical advice if Lyme Disease lymes disease lyme's disease lime disease limes disease is suspected to discuss your Lyme Disease Symptoms.
|
|
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16278426&query_hl=1
J Med Microbiol. 2005 Dec;54(Pt 12):1139-41.
Audit of the laboratory diagnosis of Lyme disease in Scotland.
Evans R, Mavin S, Ho-Yen DO.
Microbiology Department, NHS Highland, Raigmore Hospital, Inverness
IV2 3UJ, UK.
An audit was performed on the laboratory diagnosis of Lyme disease
in Scotland.
The problem of a significant number of patients with
clinical symptoms of Lyme disease being reported as seronegative or
equivocal by the confirmatory Western blot test was identified.
Comparisons of current practice were made with American and European
standards, and the Western blot scoring system revised. When applied
retrospectively (April 2003 to March 2004), 39 (33 %) of 116 serum
samples previously negative or equivocal became weak positive or
stronger.
Thirty-one (80 %) of these 39 samples were from patients with
clinical details suggestive of early Lyme disease. The changes were
implemented and assessed prospectively for 6 months.
There was a
significant increase in the proportion of equivocal results, with fewer
negatives compared to the same time period 1 year previously. This audit
has helped clinicians in the diagnosis of Lyme disease and the
management of these patients in Scotland.
PMID: 16278426 [PubMed - in process]
TOP
|
|
